Literature DB >> 34837432

Recommendations by the ClinGen Rett/Angelman-like expert panel for gene-specific variant interpretation methods.

Dianalee McKnight1, Lora Bean2, Izabela Karbassi3, Katelynn Beattie4, Thierry Bienvenu5, Hope Bonin6, Ping Fang7, John Chrisodoulou8,9, Michael Friez10, Maria Helgeson1, Rahul Krishnaraj9,11, Linyan Meng7, Lindsey Mighion4, Jeffrey Neul12, Alan Percy13, Simon Ramsden6, Huda Zoghbi7, Soma Das14.   

Abstract

The genes MECP2, CDKL5, FOXG1, UBE3A, SLC9A6, and TCF4 present unique challenges for current ACMG/AMP variant interpretation guidelines. To address those challenges, the Rett and Angelman-like Disorders Variant Curation Expert Panel (Rett/AS VCEP) drafted gene-specific modifications. A pilot study was conducted to test the clarity and accuracy of using the customized variant interpretation criteria. Multiple curators obtained the same interpretation for 78 out of the 87 variants (~90%), indicating appropriate usage of the modified guidelines the majority of times by all the curators. The classification of 13 variants changed using these criteria specifications compared to when the variants were originally curated and as present in ClinVar. Many of these changes were due to internal data shared from laboratory members however some changes were because of changes in strength of criteria. There were no two-step classification changes and only 1 clinically relevant change (Likely pathogenic to VUS). The Rett/AS VCEP hopes that these gene-specific variant curation rules and the assertions provided help clinicians, clinical laboratories, and others interpret variants in these genes but also other fully penetrant, early-onset genes associated with rare disorders.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  Angelman syndrome; Christianson syndrome; Pitt-Hopkins syndrome; Rett syndrome; guidelines; variant interpretation

Mesh:

Year:  2021        PMID: 34837432      PMCID: PMC9135956          DOI: 10.1002/humu.24302

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.700


  66 in total

1.  RettBASE: Rett syndrome database update.

Authors:  Rahul Krishnaraj; Gladys Ho; John Christodoulou
Journal:  Hum Mutat       Date:  2017-06-09       Impact factor: 4.878

2.  Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants.

Authors:  Claude Houdayer; Virginie Caux-Moncoutier; Sophie Krieger; Michel Barrois; Françoise Bonnet; Violaine Bourdon; Myriam Bronner; Monique Buisson; Florence Coulet; Pascaline Gaildrat; Cédrick Lefol; Mélanie Léone; Sylvie Mazoyer; Danielle Muller; Audrey Remenieras; Françoise Révillion; Etienne Rouleau; Joanna Sokolowska; Jean-Philippe Vert; Rosette Lidereau; Florent Soubrier; Hagay Sobol; Nicolas Sevenet; Brigitte Bressac-de Paillerets; Agnès Hardouin; Mario Tosi; Olga M Sinilnikova; Dominique Stoppa-Lyonnet
Journal:  Hum Mutat       Date:  2012-05-11       Impact factor: 4.878

3.  Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor.

Authors:  Matthew J Lyst; Robert Ekiert; Daniel H Ebert; Cara Merusi; Jakub Nowak; Jim Selfridge; Jacky Guy; Nathaniel R Kastan; Nathaniel D Robinson; Flavia de Lima Alves; Juri Rappsilber; Michael E Greenberg; Adrian Bird
Journal:  Nat Neurosci       Date:  2013-06-16       Impact factor: 24.884

4.  Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome.

Authors:  Carolyn Schanen; Elisa J F Houwink; Naghmeh Dorrani; Jane Lane; Ruth Everett; Alice Feng; Rita M Cantor; Alan Percy
Journal:  Am J Med Genet A       Date:  2004-04-15       Impact factor: 2.802

5.  Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation.

Authors:  Y H Jiang; D Armstrong; U Albrecht; C M Atkins; J L Noebels; G Eichele; J D Sweatt; A L Beaudet
Journal:  Neuron       Date:  1998-10       Impact factor: 17.173

6.  Mutations in the C-terminus of CDKL5: proceed with caution.

Authors:  Bertrand Diebold; Chloé Delépine; Svetlana Gataullina; Andrée Delahaye; Juliette Nectoux; Thierry Bienvenu
Journal:  Eur J Hum Genet       Date:  2013-06-12       Impact factor: 4.246

7.  Comparison of Core Features in Four Developmental Encephalopathies in the Rett Natural History Study.

Authors:  Clare Cutri-French; Dallas Armstrong; Joni Saby; Casey Gorman; Jane Lane; Cary Fu; Sarika U Peters; Alan Percy; Jeffrey L Neul; Eric D Marsh
Journal:  Ann Neurol       Date:  2020-06-29       Impact factor: 10.422

8.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

9.  Clinical features and gene mutational spectrum of CDKL5-related diseases in a cohort of Chinese patients.

Authors:  Ying Zhao; Xiaoying Zhang; Xinhua Bao; Qingping Zhang; Jingjing Zhang; Guangna Cao; Jie Zhang; Jiarui Li; Liping Wei; Hong Pan; Xiru Wu
Journal:  BMC Med Genet       Date:  2014-02-25       Impact factor: 2.103

10.  CDKL5 gene status in female patients with epilepsy and Rett-like features: two new mutations in the catalytic domain.

Authors:  Hiart Maortua; Cristina Martínez-Bouzas; María-Teresa Calvo; Maria-Rosario Domingo; Feliciano Ramos; Ainhoa García-Ribes; María-Jesús Martínez; María-Asunción López-Aríztegui; Nerea Puente; Izaskun Rubio; María-Isabel Tejada
Journal:  BMC Med Genet       Date:  2012-08-06       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.